The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer

The tumor–stroma ratio (TSR) was evaluated as a promising parameter for breast cancer prognostication in clinically relevant subgroups of patients. The TSR was assessed on hematoxylin and eosin‐stained tissue slides of 1,794 breast cancer patients from the Nottingham City Hospital. An independent se...

Descripción completa

Detalles Bibliográficos
Autores principales: Vangangelt, Kiki M.H., Green, Andrew R., Heemskerk, Isabelle M.F., Cohen, Danielle, van Pelt, Gabi W., Sobral‐Leite, Marcelo, Schmidt, Marjanka K., Putter, Hein, Rakha, Emad A., Tollenaar, Rob A.E.M., Mesker, Wilma E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Tumor Immunology and Microenvironment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065011/
https://www.ncbi.nlm.nih.gov/pubmed/31901133
http://dx.doi.org/10.1002/ijc.32857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065011/
https://www.ncbi.nlm.nih.gov/pubmed/31901133
http://dx.doi.org/10.1002/ijc.32857

Ejemplares similares